Skip to main content
    N

    Neuphoria Therapeutics Inc (NEUP)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $2.48
    -0.07 (-2.75%)

    Market Cap: $13.80M

    Last updated: Nov 17, 2026 at 11:04 AM ET

    Neuphoria Therapeutics Inc (NEUP) Earnings: Report Dates and Results

    Updated Sep 2, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Neuphoria Therapeutics (NEUP) is expected to report earnings on Nov 18, 2026. In the quarter ended Jun 30, 2026, Neuphoria Therapeutics reported EPS of -$0.13, above the -$0.56 estimate. It beat the EPS estimate in 5 of the 8 most recent quarters that had an estimate.

    Earnings

    Performance (10Y)

    Beat Rate
    46%(6/13)
    Avg Surprise
    +11.21%
    Streak
    3 Q

    Upcoming Estimates

    Reports Feb 15, 2027 (est.)Period ending Dec 31, 2026
    EPS ConsensusN/A
    RangeN/A
    Revenue Consensus
    N/A
    RangeN/A
    1 analysts

    Next Report

    NEUP has an expected report date of Nov 18, 2026. No consensus estimate is on file yet for the quarter ending Dec 31, 2026.

    Earnings History

    Of the 13 quarters below that had an estimate, NEUP beat 6, missed 4 and matched 3. The widest gap in the table came in the quarter ended Sep 30, 2025, when EPS landed 236.64% below the estimate.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Jun 30, 2026-$0.13-$0.56-$0.56 - -$0.56+76.79%BeatN/A10 up, 1 downSep 2, 2026N/A
    Mar 31, 2026-$0.09-$0.56-$0.56 - -$0.56+83.93%Beat-101.4%10 up, 1 downMay 15, 2026N/A
    Dec 31, 2025$0.41-$0.56-$0.56 - -$0.56+173.21%BeatN/A10 up, 1 downFeb 17, 2026N/A
    Sep 30, 2025-$4.41-$1.31-$1.31 - -$1.31-236.64%MissN/A11 up, 0 downNov 14, 2025N/A
    Jun 30, 2025-$5.55-$3.83N/A-44.91%MissN/AN/A0 up, 0 downSep 29, 2025N/A
    Mar 31, 2025$6.55$6.44N/A+1.71%BeatN/AN/A0 up, 0 downMay 20, 2025$15.00M
    Dec 31, 2024-$1.23N/AN/AN/AN/AN/AN/A0 up, 0 downMar 17, 2025$662715
    Sep 30, 2024$0.00N/AN/AN/AN/AN/AN/AN/ANov 14, 2024N/A
    Jun 30, 2024-$0.04-$0.66N/A+93.39%BeatN/AN/AN/AAug 21, 2024N/A
    Mar 31, 2024-$33.98-$0.58N/AN/AN/AN/AN/AN/AMay 29, 2024N/A
    Dec 31, 2023-$0.64-$0.63N/A-1.19%MissN/AN/AN/AMar 30, 2024N/A
    Sep 30, 2023Not reported-$0.59N/AN/ANot reportedN/AN/AN/ANov 29, 2023N/A
    Jun 30, 2023Not reported-$0.26N/AN/ANot reportedN/AN/AN/AAug 23, 2023N/A
    Mar 31, 2023Not reported-$0.46N/AN/ANot reportedN/AN/AN/AMay 31, 2023N/A
    Dec 31, 2022-$0.66-$0.66N/A-0.64%MissN/AN/AN/AFeb 22, 2023$45371
    Sep 30, 2022-$0.70-$0.70N/A+0.11%BeatN/AN/AN/ANov 30, 2022$43023
    Jun 30, 2022-$97.20-$97.20N/A0.00%In lineN/AN/AN/AAug 25, 2022N/A
    Mar 31, 2022-$102.60-$102.60N/A0.00%In lineN/AN/AN/AJun 1, 2022$2.21M
    Dec 31, 2021-$0.51-$0.51N/A0.00%In lineN/AN/AN/AFeb 22, 2022$61380
    Sep 30, 2021-$0.81N/AN/AN/AN/AN/AN/AN/ADec 1, 2021$61281
    Last 20 quarters

    Annual EPS

    EPS for the fiscal year ended Jun 30, 2026 was -$4.22, after -$0.24 the year before. It was -$201.12 for the year ended Jun 30, 2022, the oldest of the 5 fiscal years shown.

    Fiscal year endedEPSChange
    Jun 30, 2026-$4.22N/A
    Jun 30, 2025-$0.24N/A
    Jun 30, 2024-$34.66N/A
    Jun 30, 2023-$1.36N/A
    Jun 30, 2022-$201.12N/A

    Frequently Asked Questions About NEUP

    When is Neuphoria Therapeutics's next earnings date?

    Neuphoria Therapeutics's next earnings report is expected for Nov 18, 2026.

    Did NEUP beat earnings estimates last quarter?

    Yes. Neuphoria Therapeutics reported EPS of -$0.13 for the quarter ended Jun 30, 2026, above the -$0.56 estimate, a 76.79% surprise.

    How often does NEUP beat earnings estimates?

    Neuphoria Therapeutics beat the EPS estimate in 5 of the 8 most recent quarters that had an estimate, with an average surprise of +18.29%.